Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Five peptides containing amino acid sequences from the type 1 poliovirus structural protein VP1 have been synthesized. Each of the peptides was found capable of priming the immune system of rabbits for a long-lasting, virus-neutralizing IgG antibody response following a single inoculation of intact virus. One peptide directly induced the production of neutralizing antibody.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the complete neutralization of EMCV-3 capsids with EMCV-1 antisera suggests it is not a novel serotype but rather is a divergent EMCV-1 variant.”
From Zoological transmission of encephalomyocarditis virus in the United States: Virus evolution, host ecology, and capsid antigenicity derived from an outbreak (2026) · cites this paper as [80]
Citations
Cites
Prediction of protein antigenic determinants from amino acid sequences.
Hopp, T. P., & Woods, K. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3824 · Cited by 3,705
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose
Ey, P. L., Prowse, S. J., & Jenkin, C. R. (1978) · Immunochemistry · doi:10.1016/0161-5890(78)90070-6 · Cited by 2,685
Methods of Hormone Radioimmunoassay
(1978) · Elsevier eBooks · doi:10.1016/b978-0-123-79260-0.x5001-8 · Cited by 2,077
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,065
Primary structure, gene organization and polypeptide expression of poliovirus RNA
Kitamura, N., Semler, B. L., Rothberg, P. G., Larsen, G. R., Adler, C. J., Dorner, A. J., Emini, E. A., Hanecak, R., Lee, J. J., van der Werf, S., et al. (1981) · Nature · doi:10.1038/291547a0 · Cited by 914
Self-citationBittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R. A., Rowlands, D. J., & Brown, F. (1982) · Nature · doi:10.1038/298030a0 · Cited by 820
Racaniello, V. R., & Baltimore, D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4887 · Cited by 550
Cloned Viral Protein Vaccine for Foot-and-Mouth Disease: Responses in Cattle and Swine
Kleid, D. G., Yansura, D., Small, B., Dowbenko, D., Moore, D. M., Grubman, M. J., McKercher, P. D., Morgan, D. O., Robertson, B. H., & Bachrach, H. L. (1981) · Science · doi:10.1126/science.6272395 · Cited by 498
Liu, F.-T., Zinnecker, M., Hamaoka, T., & Katz, D. H. (1979) · Biochemistry · doi:10.1021/bi00571a022 · Cited by 460
Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.
Pfaff, E., Mussgay, M., Böhm, H. O., Schulz, G. E., & Schaller, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01262.x · Cited by 361
Research works printed but not linked: 7
- Icenogle, J., Shiwen, H., Duke, G., Rueckert, R. & Anderegg, J. Virology (in the press).
- Dernick, R. Devl biol. Stand. 47, 319–333 (1981).
- Blondel, B., Crainic, R. & Horodniceanu, F. C. r. hebd. Séanc. Acad. Sci., Paris 294, 91–94 (1982).
- Laporte, J., Grosclaude, J., Vantychem, J., Bernard, S. & Rouze, P. C. r. hebd. Séanc. Acad. Sci., Paris 276, 3399–3401 (1973).
- Van der Werf, S. et al. Proc. natn. acad. Sci. U.S.A. (in the press).
- Wimmer, E., Emini, E. A. & Jameson, B. A. Rev. infect. Dis. (in the press).
- Barany, G. & Merrifield, R. B. in The Peptides (eds Gross, E. & Meienhoffer, J.) 1–284 (Academic, New York, 1979).
Cited by
Turns in Peptides and Proteins
Rose, G. D., Glerasch, L. M., & Smith, J. A. (1985) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60063-7 · Cited by 1,666
Structure of a human common cold virus and functional relationship to other picornaviruses
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., Hecht, H.-J., Johnson, J. E., Kamer, G., Luo, M., Mosser, A. G., et al. (1985) · Nature · doi:10.1038/317145a0 · Cited by 1,426
Three-Dimensional Structure of Poliovirus at 2.9 Å Resolution
Hogle, J. M., Chow, M., & Filman, D. J. (1985) · Science · doi:10.1126/science.2994218 · Cited by 1,260
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide
Emini, E. A., Hughes, J. V., Perlow, D. S., & Boger, J. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.836-839.1985 · Cited by 1,250
“c Antibody-peptide immunoglobulin G reactions were measured by enzyme-linked immunosorbent assay (6).”
BackgroundMethodResultInfluentialSelf-citationHeterologous prime-boost vaccination
Lu, S. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.016 · Cited by 481
“Early work in other non-HIV areas include small animal studies conducted by Eckhart Wimmer’s group who used synthetic peptides and inactivated polio virus for prime-boost immunizations [8].”
BackgroundComplete nucleotide sequences of all three poliovirus serotype genomes
Toyoda, H., Kohara, M., Kataoka, Y., Suganuma, T., Omata, T., Imura, N., & Nomoto, A. (1984) · Journal of Molecular Biology · doi:10.1016/0022-2836(84)90084-6 · Cited by 418
Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum Malaria
Zavala, F., Tam, J. P., Hollingdale, M. R., Cochrane, A. H., Quakyi, I., Nussenzweig, R. S., & Nussenzweig, V. (1985) · Science · doi:10.1126/science.2409595 · Cited by 367
Prediction of sequential antigenic regions in proteins
Welling, G. W., Weijer, W. J., van der Zee, R., & Welling-Wester, S. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80374-4 · Cited by 353
Gorny, M. K., Conley, A. J., Karwowska, S., Buchbinder, A., Xu, J. Y., Emini, E. A., Koenig, S., & Zolla-Pazner, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7538-7542.1992 · Cited by 308
“Usually, effective neutralization is mediated only by Abs specific for discrete epitopes on the surface of the viral particle (4, 29, 38, 40, 45).”
BackgroundSelf-citationSherry, B., Mosser, A. G., Colonno, R. J., & Rueckert, R. R. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.246-257.1986 · Cited by 299
“(5, 10), as most of these peptides spanned both sites.”
BackgroundLive recombinant vaccinia virus protects chimpanzees against hepatitis B
Moss, B., Smith, G. L., Gerin, J. L., & Purcell, R. H. (1984) · Nature · doi:10.1038/311067a0 · Cited by 281
Itoh, Y., Takai, E., Ohnuma, H., Kitajima, K., Tsuda, F., Machida, A., Mishiro, S., Nakamura, T., Miyakawa, Y., & Mayumi, M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9174 · Cited by 243
Location of the major antigenic sites involved in rotavirus serotype-specific neutralization.
Dyall-Smith, M. L., Lazdins, I., Tregear, G. W., & Holmes, I. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3465 · Cited by 239
Wu, C.-N., Lin, Y.-C., Fann, C., Liao, N.-S., Shih, S.-R., & Ho, M.-S. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00385-1 · Cited by 225
Induction of anti-HIV neutralizing antibodies by synthetic peptides.
Chanh, T. C., Dreesman, G. R., Kanda, P., Linette, G. P., Sparrow, J. T., Ho, D. D., & Kennedy, R. C. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04607.x · Cited by 227
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants
Page, G. S., Mosser, A. G., Hogle, J. M., Filman, D. J., Rueckert, R. R., & Chow, M. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1781-1794.1988 · Cited by 222
Primary structure and gene organization of human hepatitis A virus.
Najarian, R., Caput, D., Gee, W., Potter, S. J., Renard, A., Merryweather, J., Van Nest, G., & Dina, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.9.2627 · Cited by 200
Antigenic Structure of Picornaviruses
Minor, P. D. (1990) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75602-3_5 · Cited by 187
Evidence for at least two dominant neutralization antigens on human rhinovirus 14
Sherry, B., & Rueckert, R. (1985) · Journal of Virology · doi:10.1128/jvi.53.1.137-143.1985 · Cited by 179
“Sequencing studies will now be required to locate the positions of the mutations in VP1 and VP3 in HRV-14 and to determine whether the VP1 mutations on HRV-14 occur in a region homologous to the positions 70 through 75 (5) and 93 through 100 (9) in poliovirus.”
BackgroundLocation and Chemical Synthesis of a Binding Site for HIV-1 on the CD4 Protein
Jameson, B. A., Rao, P. E., Kong, L. I., Hahn, B. H., Shaw, G. M., Hood, L. E., & Kent, S. B. H. (1988) · Science · doi:10.1126/science.2453925 · Cited by 177
Self-citationCunningham, M. W., Antone, S. M., Gulizia, J. M., McManus, B. M., Fischetti, V. A., & Gauntt, C. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1320 · Cited by 176
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction
Yang, C.-F., De, L., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1991) · Virus Research · doi:10.1016/0168-1702(91)90107-7 · Cited by 144
Nyambi, P. N., Mbah, H. A., Burda, S. T., Williams, C. A. U., Górny, M. K., Nadas, A. J., & Zolla‐Pazner, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7096-7107.2000 · Cited by 139
“Partial answers come from the literature with viruses such as poliovirus and influenza virus, showing different antigenic sites on the virions involved in binding to certain “neutralization relevant and irrelevant” spikes (11, 57, 61).”
Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14.
Callahan, P. L., Mizutani, S., & Colonno, R. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.732 · Cited by 137
Antigenic Variation and Resistance to Neutralization in Poliovirus Type 1
Diamond, D. C., Jameson, B. A., Bonin, J., Kohara, M., Abe, S., Itoh, H., Komatsu, T., Arita, M., Kuge, S., Nomoto, A., et al. (1985) · Science · doi:10.1126/science.2412292 · Cited by 125
Self-citationBlondel, B., Crainic, R., Fichot, O., Dufraisse, G., Candrea, A., Diamond, D., Girard, M., & Horaud, F. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.81-90.1986 · Cited by 121
“In the present paper, we adopted the following nomenclature, in correspondence (Table 1) with that of previous publications in which the same N-mcAbs were used (2, 4, 9, 10, 12, 13, 16, 18, 22, 23, 45, 47).”
BackgroundMethodInfluentialA gene fusion system for generating antibodies against short peptides
Löwenadler, B., Jansson, B., Paleus, S., Houngren, E., Nilsson, B., Moks, T., Palm, G., Josephson, S., Philipson, L., & Uhlén, M. (1987) · Gene · doi:10.1016/0378-1119(87)90032-1 · Cited by 120
A Poliovirus Neutralization Epitope Expressed on Hybrid Hepatitis B Surface Antigen Particles
Delpeyroux, F., Chenciner, N., Lim, A., Malpièce, Y., Blondel, B., Crainic, R., van der Werf, S., & Streeck, R. E. (1986) · Science · doi:10.1126/science.2425433 · Cited by 114
Chow, M., Yabrov, R., Bittle, J. L., Hogle, J. M., & Baltimore, D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.910 · Cited by 111
Synthetic peptides: a next generation of vaccines?
Steward, M. W., & Howard, C. R. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90239-8 · Cited by 102
Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus
Kniess, N., Mach, M., Fay, J., & Britt, W. J. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.138-146.1991 · Cited by 99
“Similar observations have been reported in other viruses, including human immunodeficiency virus, foot-and-mouth disease virus, and poliovirus, in which linear neutralizing epitopes were localized to 26, 19, and 11 AA, respectively (6, 17, 29).”
BackgroundResultMorgan, A. J., Mackett, M., Finerty, S., Arrand, J. R., Scullion, F. T., & Epstein, M. A. (1988) · Journal of Medical Virology · doi:10.1002/jmv.1890250209 · Cited by 98
Langeveld, J., Casal, J. I., Vela, C., Dalsgaard, K., Smale, S. H., Puijk, W. C., & Meloen, R. H. (1993) · Journal of Virology · doi:10.1128/jvi.67.2.765-772.1993 · Cited by 98
“, by immunizing experimental animals with synthetic peptides deduced from VP1 of poliovirus (6, 9, 31).”
MethodImmunological Priming with Synthetic Peptides of Foot-and-Mouth Disease Virus
Francis, M. J., Fry, C., Rowlands, D. J., Brown, F., Bittle, J. L., Houghten, R. A., & Lerner, R. A. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-11-2347 · Cited by 98
Murray, M. G., Kuhn, R. J., Arita, M., Kawamura, N., Nomoto, A., & Wimmer, E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3203 · Cited by 91
Self-citationThe role of structure in antibody cross-reactivity between peptides and folded proteins
Craig, L., Sanschagrin, P. C., Rozek, A., Lackie, S. J., Kuhn, L. A., & Scott, J. K. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1907 · Cited by 90
Nobis, P., Zibirre, R., Meyer, G., Kuhne, J., Warnecke, G., & Koch, G. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-12-2563 · Cited by 88
Selinka, H. C., Zibert, A., & Wimmer, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3598 · Cited by 87
Self-citationSynthetic T and B Cell Recognition Sites: Implications for Vaccine Development
Milich, D. R. (1989) · Advances in immunology · doi:10.1016/s0065-2776(08)60694-x · Cited by 86
Dowd, K. A., DeMaso, C. R., & Pierson, T. C. (2015) · mBio · doi:10.1128/mbio.01559-15 · Cited by 81
“However, the X-ray crystal structure of the virus subsequently revealed that this region of VP1 is situated on the interior of the virion, suggesting that multiple conformations of poliovirus capsid exist (48).”
BackgroundIdentification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1
Leclerc, C., Deriaud, E., Mimic, V, & van der Werf, S. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.711-718.1991 · Cited by 83
Emini, E. A., Ostapchuk, P., & Wimmer, E. (1983) · Journal of Virology · doi:10.1128/jvi.48.2.547-550.1983 · Cited by 83
Self-citationHaynes, J. R., Cunningham, J., von Seefried, A., Lennick, M., Garvin, R. T., & Shen, S.-H. (1986) · Nature Biotechnology · doi:10.1038/nbt0786-637 · Cited by 80
Isolation and characterization of a major cross-reactive grass group I allergenic determinant
Esch, R. E., & Klapper, D. G. (1989) · Molecular Immunology · doi:10.1016/0161-5890(89)90007-2 · Cited by 80
Maharjan, P. M., & Choe, S. (2021) · Vaccines · doi:10.3390/vaccines9090992 · Cited by 78
The immunology of new generation vaccines
Zanetti, M., Sercarz, E. E., & SALK, J. E. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90827-9 · Cited by 78
Young, A. C. M., Valadon, P., Casadevall, A., Scharff, M. D., & Sacchettini, J. C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1407 · Cited by 83
Ferguson, M. A. J., Evans, D. M. A., Magrath, D. I., Minor, P. D., Almond, J. W., & Schild, G. C. (1985) · Virology · doi:10.1016/0042-6822(85)90389-7 · Cited by 75
Soloway, P. D., Fish, S., Passmore, H., Gefter, M. L., Coffee, R., & Manser, T. L. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.847 · Cited by 72
“Downloaded from jem.rupress.org on December 14, 2009 Published October 1, 1991 antibody responses ( 15-17 ).”
MethodRecent Advances in the Use of Plant Virus-Like Particles as Vaccines
Baļķe, I., & Zeltiņš, A. (2020) · Viruses · doi:10.3390/v12030270 · Cited by 74
Roivainen, M., Närvänen, A. T. O., Korkolainen, M., Huhtala, M., & Hovi, T. (1991) · Virology · doi:10.1016/0042-6822(91)90013-2 · Cited by 70
Ziegler, D. L., Fournier, P., Berbers, G. A. H., Steuer, H., Wiesmüller, K. H., Fleckenstein, B. T., Schneider, F., Jung, G., King, C., & Muller, C. P. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-10-2479 · Cited by 69
Fricks, C. E., Icenogle, J. P., & Hogle, J. M. (1985) · Journal of Virology · doi:10.1128/jvi.54.3.856-859.1985 · Cited by 70
“First, consistent with the results of studies in which other methods were used, the tryptic sensitivity which we observed indicates that the region around amino acid 99 is exposed on the viral surface (1, 3, 16).”
ResultMuller, S., Plaue, S., Samama, J., Valette, M., Briand, J., & Regenmortel, M. H. V. V. (1990) · Vaccine · doi:10.1016/0264-410x(90)90086-2 · Cited by 69
Kappes, J. C., Morrow, C. D., Lee, S., Jameson, B. A., Kent, S. B. H., Hood, L., Shaw, G. M., & Hahn, B. H. (1988) · Journal of Virology · doi:10.1128/jvi.62.9.3501-3505.1988 · Cited by 73
Self-citationRotavirus Vaccines and Vaccination Potential
Conner, M. E., Matson, D. O., & Estes, M. K. (1994) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-78256-5_10 · Cited by 64
Hughes, J. V., Stanton, L. W., Tomassini, J. E., Long, W. J., & Scolnick, E. M. (1984) · Journal of Virology · doi:10.1128/jvi.52.2.465-473.1984 · Cited by 63
Palfreyman, J. W., Aitcheson, T. C., & Taylor, P. L. (1984) · Journal of Immunological Methods · doi:10.1016/0022-1759(84)90122-4 · Cited by 63
Contraceptive potential of antibodies to the zona pellucida
Henderson, C. J., Hulme, M. J., & Aitken, R. J. (1988) · Reproduction · doi:10.1530/jrf.0.0830325 · Cited by 62
Type 1 fimbriae of Escherichia coli as carriers of heterologous antigenic sequences
Hedegaard, L., & Klemm, P. (1989) · Gene · doi:10.1016/0378-1119(89)90471-x · Cited by 62
Enteroviruses: epidemic potential, challenges and opportunities with vaccines
Jartti, M., Flodström‐Tullberg, M., & Hankaniemi, M. M. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01058-x · Cited by 61
“However, partial neutralization of related enterovirus serotypes has been observed when studying serotype-specific sera [208], and several monoclonal antibodies (mAbs) that bind and neutralize multiple poliovirus serotypes have been isolated from infected humans [209].”
BackgroundPoliovirus and Other Enteroviruses
Melnick, J. L. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0036-4_21 · Cited by 66
Antigenicity and Immunogenicity of Synthetic Peptides of Foot-and-Mouth Disease Virus
Meloen, R. H., Puyk, W. C., Meijer, D. J. A., Lankhof, H., Posthumus, W. P. A., & Schaaper, W. M. M. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-2-305 · Cited by 60
El-Sayed, N. M., & Donelson, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26742 · Cited by 58
The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens
Andino, R., Kirkegaard, K., Macadam, A. J., Racaniello, V. R., & Rosenfeld, A. B. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac426 · Cited by 53
den Hurk, S. V. D. L., Hurk, L.-V. D., & BABIUK, L. A. (1985) · Virology · doi:10.1016/0042-6822(85)90318-6 · Cited by 53
Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses
Nitayaphan, S., Tóth, M., & Roos, R. P. (1985) · Journal of Virology · doi:10.1128/jvi.53.2.651-657.1985 · Cited by 52
Synthetic Peptides as Diagnostic Tools in Virology
Leinikki, P., Lehtinen, M., Hyöty, H., Parkkonen, P., Ml, K., & Hakulinen, J. (1993) · Advances in virus research · doi:10.1016/s0065-3527(08)60085-8 · Cited by 56
Myristylated polyomavirus VP2: role in the life cycle of the virus
Krauzewicz, N., Streuli, C. H., Stuart-Smith, N., Jones, M. D., Wallace, S., & Griffin, B. E. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4414-4420.1990 · Cited by 51
Bergen, R., Diaz, P. S., & Arvin, A. M. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1049 · Cited by 51
Emini, E. A., Leibowitz, J., Diamond, D. C., Bonin, J., & Wimmer, E. (1984) · Virology · doi:10.1016/0042-6822(84)90010-2 · Cited by 53
Self-citationINDUCTION OF LONG-TERM IMMUNITY TO PARALYTIC POLIOMYELITIS BY USE OF NON-INFECTIOUS VACCINE
Salk, D., van Wezel, A. L., & SALK, J. E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90830-4 · Cited by 48
Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
Garg, I., Sheikh, A. B., Pal, S., & Shekhar, R. (2022) · Infectious Disease Reports · doi:10.3390/idr14040057 · Cited by 50
Strynadka, N. C. J., Redmond, M. J., Parker, J. M. R., Scraba, D. G., & Hodges, R. S. (1988) · Journal of Virology · doi:10.1128/jvi.62.9.3474-3483.1988 · Cited by 47
“For example, antigenic peptides have been synthesized which correspond to protein segments of influenza A (26), polio (14), and hepatitis B (29) viruses.”
BackgroundSynthetic peptide vaccines: success at last
Meloen, R. H., Casal, J. I., Dalsgaard, K., & Langeveld, J. (1995) · Vaccine · doi:10.1016/0264-410x(95)00031-u · Cited by 46
Jacob, C. O., Leitner, M., Zamir, A., Salomon, D., & Arnon, R. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04086.x · Cited by 45
Salk, D., & SALK, J. E. (1984) · Vaccine · doi:10.1016/s0264-410x(98)90035-4 · Cited by 44
Mariani, M., Bracci, L., Presentini, R., Nucci, D., Neri, P., & Antoni, G. (1987) · Molecular Immunology · doi:10.1016/0161-5890(87)90148-9 · Cited by 44
The antigenic structure of poliovirus
Hogle, J. M., & Filman, D. J. (1989) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1989.0024 · Cited by 45
Identification of a new neutralization antigenic site on poliovirus coat protein VP2
Emini, E. A., Jameson, B. A., & Wimmer, E. (1984) · Journal of Virology · doi:10.1128/jvi.52.2.719-721.1984 · Cited by 42
“It should be added that this serum failed to precipitate denatured VP2, as did sera elicited against VP1-specific peptides that do not recognize VP1 (10).”
BackgroundMethodResultSelf-citationLizano, M., López, S., & Arias, C. F. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1383-1391.1991 · Cited by 42
“Recently, several reports have appeared in which proteins or synthetic peptides of viral origin can specifically prime the immune system of animals for a virus-neutralizing antibody response after a single inoculation of intact virus (1, 8).”
BackgroundMurdin, A. D., & Wimmer, E. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5251-5257.1989 · Cited by 41
Self-citationReplicase gene of coxsackievirus B3
Stålhandske, P., Lindberg, M. R., & Pettersson, U. (1984) · Journal of Virology · doi:10.1128/jvi.51.3.742-746.1984 · Cited by 40
“These sequences have provided valuable information concerning genome structure and how attenuation may be determined by alterations in the VP1 protein, claimed to be the most important antigen in the enterovirus coat (2, 6, 7, 21, 25).”
BackgroundCello, J., Samuelson, A., Stålhandske, P., Svennerholm, B., Jeansson, S. L., & Forsgren, M. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.911-916.1993 · Cited by 39
Synthetic peptides as the basis for future vaccines
Arnon, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90088-5 · Cited by 39
MY ROLE IN THE DISCOVERY AND CLASSIFICATION OF THE ENTEROVIRUSES
Melnick, J. L. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.1 · Cited by 38
Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence
Freistadt, M. S., & Eberle, K. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6486-6492.1996 · Cited by 38
“Samples were withdrawn at daily intervals, and viral titers were determined in an independent plaque assay in HeLa cells (12), except that plaque assays for PV(2) and PV(3) isolates were stained after 3 days rather than after 2 days, as was done for the PV(1) assays.”
MethodJohnston, J. M., Harmon, S. A., Binn, L. N., Richards, O. C., Ehrenfeld, E., & Summers, D. F. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/157.6.1203 · Cited by 37
“sponse after single inoculation of intact virus [30].”
BackgroundMuller, S. (1999) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(08)70447-9 · Cited by 37
Nestorowicz, A., Tregear, G. W., Southwell, C., Martyn, J. C., Murray, J. M., WHITE, D. O., & Jackson, D. C. (1985) · Molecular Immunology · doi:10.1016/s0161-5890(85)80008-0 · Cited by 37
Redmond, M. J., Bielefeldt‐Ohmann, H., Hughes, H. P. A., Sabara, M. I. J., Frenchick, P. J., ATTAH‐POKU, S. K., Ijaz, M. K., Parker, M. D., Laarveld, B., & Babiuk, L. A. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90073-s · Cited by 35
Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses
Rosenfeld, A. B., Shen, E. Q.-L., Melendez, M., Mishra, N., Lipkin, W. I., & Racaniello, V. R. (2022) · mBio · doi:10.1128/mbio.03660-21 · Cited by 34
“tion is not absolute: individual serotypes may be incompletely neutralized by antibodies raised against the other two serotypes (28), suggesting that antibodies able to neu-”
BackgroundMcPhee, F., Zell, R., Reimann, B.-Y., HOFSCHNEIDER, P. H., & Kandolf, R. (1994) · Virus Research · doi:10.1016/0168-1702(94)90096-5 · Cited by 37
Eberle, K. E., Nguyen, V. T., & Freistadt, M. S. (1995) · Archives of Virology · doi:10.1007/bf01323236 · Cited by 34
“Virions were titered in a standard plaque assay on Hela R19 cells [6] .”
MethodGilbert, J. H., Pedersen, N. C., & Nunberg, J. H. (1987) · Virus Research · doi:10.1016/0168-1702(87)90057-8 · Cited by 34
Emini, E. A., Schleif, W. A., Colonno, R. J., & Wimmer, E. (1985) · Virology · doi:10.1016/0042-6822(85)90441-6 · Cited by 33
Self-citationKabilan, L., Troye‐Blomberg, M., Patarroyo, M. E., Björkman, A., & Perlmann, P. (1987) · PubMed Central · Cited by 32
Murdin, A. D., Su, H., Manning, D. S., Klein, M., Parnell, M. J., & Caldwell, H. D. (1993) · Infection and Immunity · doi:10.1128/iai.61.10.4406-4414.1993 · Cited by 34
Delpeyroux, F., Wezel, E. V., Blondel, B., & Crainic, R. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.6090-6100.1990 · Cited by 31
“The continuous nature of some neutralization-antigenic determinants of N-AgI was demonstrated in different ways for PV-1 and PV-3 (4, 8, 18, 20, 25, 49).”
BackgroundDelpeyroux, F., Peillon, N., Blondel, B., Crainic, R., & Streeck, R. E. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1836-1839.1988 · Cited by 30
“Neutralizing antibodies have also been obtained by immunization of rabbits with polypeptides overlapping the sequence used in HBsPolioAg (7-9).”
Method
Metadata
- Authors
- Emini, E. A., Jameson, B. A., & Wimmer, E.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- State University of New York (US)
- ORCID
- Wimmer, Eckard
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5928
- Pages
- 699-703
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989110977
- Cited by
- 237
- References
- 33
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 28.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- poliovirus type 1, synthetic peptides, peptide immunization, immune priming, neutralizing antibodies, IgG antibody response, rabbit immunization
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antibodies, Viral, Antigen-Antibody Complex, Antigens, Viral, Enzyme-Linked Immunosorbent Assay, Peptides, Rabbits, Poliovirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.